Search results for "Colore"

showing 10 items of 1250 documents

Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer

2022

Approximately 50% of colorectal cancer (CRC) patients still die from recurrence and metastatic disease, highlighting the need for novel therapeutic strategies. Drug repurposing is attracting increasing attention because, compared to traditional de novo drug discovery processes, it may reduce drug development periods and costs. Epidemiological and preclinical evidence support the antitumor activity of antipsychotic drugs. Herein, we dissect the mechanism of action of the typical antipsychotic spiperone in CRC. Spiperone can reduce the clonogenic potential of stem-like CRC cells (CRC-SCs) and induce cell cycle arrest and apoptosis, in both differentiated and CRC-SCs, at clinically relevant co…

cancer stem cellsCancer ResearchrepurposingNeoplasms. Tumors. Oncology. Including cancer and carcinogenscolorectal cancerpsychotropic drugsrepurposing; phospholipase C; colorectal cancer; endoplasmic reticulum stress; intracellular calcium; lipid metabolism; psychotropic drugs; cancer stem cells; mitochondria; GolgimitochondriaOncologylipid metabolism&nbspGolgiendoplasmic reticulum stressSettore MED/46 - Scienze Tecniche Di Medicina Di Laboratoriophospholipase CRC254-282intracellular calciumCancers
researchProduct

Expresión de microRNAs en la zonas de transición epitelio mesenquimal en el carcinoma colorectal como factor inmunomodulador y pronóstico. Estudio cl…

2018

El subgrupo mesenquimal (CMS4) de la clasificación molecular de consenso de cáncer colorectal es el tipo más agresivo y de peor pronóstico, y se caracteriza por la sobre expresión de genes implicados en el mecanismo de transición epitelio mesenquimal (TEM). La desdiferenciación tumoral focal (DTF) es el reflejo histológico del proceso de TEM. En base a estos conocimientos nos planteamos explorar la influencia de la DTF en la expresión de genes y microRNAs implicados en el proceso de TEM y evaluar su utilidad como factores predictivos de supervivencia. Analizamos de forma retrospectiva el grado de DTF en una serie de 125 especímenes de colectomía en todos los estadios clínicos. Evaluamos la …

carcinoma colorectaltransición epitelio mesenquimalUNESCO::CIENCIAS MÉDICAS:CIENCIAS MÉDICAS [UNESCO]micrornas
researchProduct

Effetti di mutazioni diverse di ras in cellule di carcinoma colorettale (HT29)

2011

cellule di carcinoma colorettale (HT29).mutazioni diverseSettore BIO/11 - Biologia Molecolarera
researchProduct

Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-sp…

2012

Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor receptor, approved for colorectal carcinoma treatment in combination with chemotherapy. The immune-mediated effects elicited by its human fraction of crystallization moiety might critically contribute to the overall anti-tumor effectiveness of the antibody. We therefore investigated cetuximab ability to promote colon cancer cell opsonization and phagocytosis by human dendritic cells (DCs) that are subsequently engaged in antigen-cross presentation to cytotoxic T-lymphocyte (CTL) precursors. Human colon cancer cell lines were evaluated for susceptibility to DC-mediated phagocytosis before and after …

cetuximab; chemotherapy; danger signal; cytotoxic-T-lymphocytes; phagocytosisCancer ResearchColorectal cancerSettore MED/06 - Oncologia MedicaAntigen-Presenting CellsAntibodies Monoclonal Humanizedchemotherapydanger signalCross-PrimingAntigenAntigens NeoplasmCell Line TumorAntineoplastic Combined Chemotherapy ProtocolscetuximabHumansMedicineCytotoxic T cellCetuximabbusiness.industrySettore BIO/14Antibodies MonoclonalphagocytosisDendritic CellsDendritic cellmedicine.diseasecytotoxic-T-lymphocytedigestive system diseasesTumor antigenCTL*OncologyColonic NeoplasmsCancer cellImmunologyLeukocytes MononuclearCancer researchbusinessHT29 Cellscytotoxic-T-lymphocytesT-Lymphocytes Cytotoxicmedicine.drug
researchProduct

Bleaching of color of kraft pulp mill effluents and natural organic matter in lakes

2002

In situ changes in the color of lake water and biologically treated kraft pulp mill effluents mixed in lake water were examined in three lakes. In 1.7 m3 enclosures, the color (400–700 g Pt·m–3) of the mixture of pulp mill effluent and lake water remained similar for 4 months in darkness, whereas exposure to solar radiation resulted in 17–42% bleaching of color. During the summer stratification of a humic lake, the color (160 g Pt·m–3) of hypolimnetic water remained similar to that found during spring turnover, but the color of epilimnion decreased 13%. The measured rates of photochemical bleaching of color by solar radiation could explain the decrease of epilimnetic color. Attenuation of …

chemistry.chemical_classificationbusiness.industryEcologyPaper millAquatic SciencePulp and paper industryNatural organic matterColored dissolved organic matterchemistryKraft processEpilimnionEnvironmental scienceMillOrganic matterbusinessEffluentEcology Evolution Behavior and SystematicsCanadian Journal of Fisheries and Aquatic Sciences
researchProduct

Omega-3 PUFAs and gut microbiota: A preventive approach for colorectal cancer

2021

The influence of diet on the composition of the intestinal microbiota and related pathologies has been known for some time. Some classes of nutrients, such as fatty acids belonging to the omega 3 series, have particular effects on the bacteria that make up the intestinal microbiota. ω-3 PUFAs affect the gut microbiota in three different ways: by modulating the type and abundance of intestinal bacteria, by regulate SCFAs levels, and by alter the levels of proinflammatory mediators. Through these modalities, ω-3 PUFAs could be useful for the prevention of intestinal diseases such as Colorectal Cancer (CRC). The ability of ω-3 PUFAs to modulate the intestinal inflammatory response, to preserve…

chemistry.chemical_classificationω-3 PUFAsgut microbiotabiologyQH301-705.5Colorectal cancerbusiness.industryBiochemistry (medical)colorectal cancerPlant ScienceGut florabiology.organism_classificationmedicine.diseaseBioinformaticsdigestive systemGeneral Biochemistry Genetics and Molecular BiologyMucosal Associated Lymphatic Tissue (MALT)preventionchemistrymedicineBiology (General)businesscolorectale cancer prevention gut microbiota mucosal associated lymphatic tissue omega-3 PUFAsPolyunsaturated fatty acidJournal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
researchProduct

Nuclear protein phosphatase Wip1 regulate sensitivity of human colorectal cancer cells to DNA damaging anti-cancer agents

2019

chemistry.chemical_compoundchemistryColorectal cancerbusiness.industryPhosphatasemedicineCancer researchCancerNuclear proteinmedicine.diseasebusinessGeneral Biochemistry Genetics and Molecular BiologyDNABiopolymers and Cell
researchProduct

Role of epigenetic factors in the selection of the alternative splicing isoforms of human

2017

Mutation-driven activation of KRAS is crucial to cancer development. The human gene yields four mRNA splicing isoforms, 4A and 4B being translated to protein. Their different properties and oncogenic potential have been studied, but the mechanisms deciding the ratio 4A/4B are not known. To address this issue, the expression of the four KRAS isoforms was determined in 9 human colorectal cancer cell lines. HCT116 and SW48 were further selected because they present the highest difference in the ratio 4A/4B (twice as much in HCT116 than in SW48). Chromatin structure was analysed at the exon 4A, characteristic of isoform 4A, at its intronic borders and at the two flanking exons. The low nucleoso…

chromatin structurealternative splicingKRAS isoformsepigeneticscolorectal cancerResearch PaperOncotarget
researchProduct

Malignant colorectal obstruction. Palliative endoscopic treatment with self-expanding metallic stents

2005

The Authors report their experience in the palliative management of malignant colorectal obstruction. Between June 2000 and April 2003 sixteen patients (11 men and 5 women, age range 63-82) were found suffering from malignant colorectal obstruction. In these patients it was not possible to perform definitive surgical treatment because of the old age, advanced neoplastic disease and poor health condition, colostomy was the only therapeutic option. Endoscopic self-expanding stents placement was performed as a definitive palliative method to treat colorectal obstructions caused by advanced and unresectable tumours. This procedure was performed under endoscopic and fluoroscopic control and neit…

colorectal cancer endoscopic treatment self-expanding stents
researchProduct

Developing liver spheroids for elucidating the role of colorectal cancer-derived smallextracellular vesicles in the pre-metastatic niche formation

2022

Introduction: Colorectal cancer (CRC) is the third most common tumor in the world frequently associated with liver metastasiscausing unfavorable prognosis. A recent study performed in our laboratory has demonstrated that CRC small extracellular vesi-cles (SEVs) induce an epithelial to mesenchymal transition (EMT) of hepatocytes (heps) driving them to actively participate inthe pre-metastatic niche formation, probably contributing to form a liver fibrotic microenvironment. Since 2D cell cultures par-tially reflect the structural complexity of the in vivo microenvironment to give more power to our functional model, we switchedto use hepatocyte spheroids (HeSPHs), which can give us more proper…

colorectal cancer liver extracellular vesicles
researchProduct